Gajender Singh
About Gajender Singh
Gajender Singh has 22 years in corporate governance. Holds Director role. Currently with 4 companies, including Virtuous Homes Private Limited and Gat Pharmaceuticals Private Limited. Formerly with 1 company, such as Hill Guards And Services Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Virtuous Homes Private Limited
U70109HR2012PTC048032
|
Director | 28 Dec 2012 | 2012 | Active |
Gat Pharmaceuticals Private Limited
U74999CH2016PTC041251
|
Director | 13 Oct 2016 | 2016 | Active |
Virtuous Vision Private Limited
U92190HR2012PTC046587
|
Director | 01 Feb 2022 | 2012 | Active |
Ambitious Entertainment Private Limited
U92199HR2003PTC035260
|
Director | 09 Dec 2003 | 2003 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Hill Guards And Services Private Limited
U74899DL1988PTC032500
|
Director | 16 Jul 2021 | 1988 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gajender Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gajender Singh
Gajender Singh has 22 years in corporate governance. Holds Director role. Currently with 4 companies, including Virtuous Homes Private Limited and Gat Pharmaceuticals Private Limited. Formerly with 1 company, such as Hill Guards And Services Private Limited. Engaged in General Business. Contributes to corporate operations.
Gajender Singh is associated with 4 companies as Director.
Gajender Singh has expertise in General Business.
Gajender Singh has 22 years in corporate governance.